EZH2 and neoplasm: MAGE-C2/CT-10 should be added to the list of proposed prognostic tumor progression markers, including MUC1 [55], AZGP1 [55], EZH2 [56], E2F3 [57], Ki67 [58],[59], and CD10 [60].